TRINITY BIOTECH INVT LTD - NOTE 4.000% 4/0 Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2016 to Q1 2024

Type / Class
Debt / NOTE 4.000% 4/0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of TRINITY BIOTECH INVT LTD - NOTE 4.000% 4/0 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2024 Q1 $0 $0 -$10,000 0
2023 Q4 $15,000 $10,000 +$10,000 66.67% 1
2022 Q1 $0 $0 -$78,329,000 0
2021 Q4 $99,705,000 $78,329,000 +$13,000 86.29% 4
2021 Q3 $92,690,000 $67,637,000 73.31% 2
2021 Q2 $92,690,000 $69,366,000 75.5% 2
2021 Q1 $92,690,000 $69,366,000 75.5% 2
2020 Q4 $92,690,000 $67,390,000 +$177,499 73.0% 2
2020 Q3 $92,440,000 $63,487,000 -$204,338 68.62% 2
2020 Q2 $92,440,000 $64,600,000 +$14,635 69.89% 3
2020 Q1 $92,440,000 $65,609,000 70.0% 3
2019 Q4 $92,440,000 $68,757,000 -$73,681 75.29% 3
2019 Q3 $92,440,000 $64,657,000 71.24% 4
2019 Q2 $92,440,000 $69,960,000 75.28% 4
2019 Q1 $92,440,000 $71,541,000 77.21% 4
2018 Q4 $92,440,000 $71,551,000 77.85% 4
2018 Q3 $92,440,000 $73,128,000 +$2,461,396 79.0% 4
2018 Q2 $87,467,100 $71,623,616 -$37,731 82.32% 5
2018 Q1 $87,467,100 $70,777,947 +$787,304 80.81% 5
2017 Q4 $86,492,800 $71,097,396 +$13,618 82.28% 5
2017 Q3 $86,492,900 $69,179,651 -$122 80.53% 5
2017 Q2 $86,493,050 $69,764,896 +$1,299,196 81.61% 5
2017 Q1 $84,894,650 $69,028,979 -$366,743 81.55% 6
2016 Q4 $85,344,650 $97,401,000 +$718,430 84.86% 6
2016 Q3 $92,769,650 $108,146,000 +$252,091 96.32% 9
2016 Q2 $92,413,050 $102,285,000 +$77,481,000 91.53% 9
2016 Q1 $7,870,050 $25,128,000 +$17,932,000 44764.04% 2